ITOS — iTeos Therapeutics Share News
0.000.00%
Last trade - 00:00- $448.68m
- -$66.75m
- $35.00m
Iteos Therapeutics Inc expected to post a loss of $1.01 a share - Earnings Preview
Brief: Iteos Therapeutics Enters Into Agreement To Be Acquired By Concentra Biosciences For $10.047 In Cash Per Share Plus A Contingent Value Right
U.S. STOCKS ON THE MOVE-Nvidia, Salesforce, Kestrel Group
U.S. STOCKS ON THE MOVE-Dick's Sporting Goods, Sonic Automotive
Brief: I Teos Therapeutics Inc Expected Severance Costs Of $21.8 Million To $24.7 Million
ITeos rises on plans to explore asset sales, use cash reserves
Drug developer iTeos to shut down operations after cancer therapy setback (updated)
iTeos plans to shut down operations after cancer therapy setback
U.S. RESEARCH ROUNDUP-Fair Issac, First Solar, UnitedHealth
iTeos rises as it looks to conserve cash after cancer drug setback
British stocks mixed as investors assess US inflation, UK labour market report (updated)
ITeos, GSK discontinue lung cancer therapy development (updated)
ITeos, GSK discontinue lung cancer therapy development
iTeos Therapeutics rises after reporting narrower-than-expected quarterly loss
Iteos Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary
Iteos Therapeutics Inc expected to post a loss of $1.06 a share - Earnings Preview
U.S. RESEARCH ROUNDUP- AMN Healthcare Services, Chart Industries, Home Depot
Iteos Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary
Iteos Therapeutics Inc expected to post a loss of 89 cents a share - Earnings Preview